Protagonist Therapeutics (PTGX) Q2 2023 Earnings

3AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.87
-0.78
-0.68
-0.59

Details

Expected EPS
-0.65
Actual EPS
-0.68
Surprise EPS
-0.03
Surprise Percent
+4.62%

Description

Protagonist Therapeutics (PTGX) has reported earnings of -0.68 per share for Q2 2023.

0 Comments

Share your thoughts